Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06323525
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-03-08
Brief Title:
TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in rr B Cell Lymphoma
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Organization Data
Organization:
Chinese PLA General Hospital
Class:
OTHER
Study ID:
CHN-PLAGH-BT-083
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese PLA General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Han weidong
Responsible Party Title:
Director of Biotherapeutic Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chinese PLA General Hospital
Old Name:
None
Old Organization:
None